Skip to Main Content

Author Details

Merrill Eric Gershwin
Allergy and Clinical Immunology, University of California at Davis
1967
1310
114
PMIDPaper TitleJournal TitlePublished Year
38040101Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications.Autoimmun Rev2024
37945156Autoimmune Hepatitis: Pathophysiology.Clin Liver Dis2024
37505225Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis.Hepatology2024
35987275Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.J Hepatol2023
37748979The gut ecosystem and immune tolerance.J Autoimmun2023
37659731A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.J Hepatol2023
37826920Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review.J Autoimmun2023
38089552Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1.JHEP Rep2023
37390745Molecular mimicry and autoimmunity in the time of COVID-19.J Autoimmun2023
37348755Differential regulation of JAK1 expression by ETS1 associated with predisposition to primary biliary cholangitis.J Genet Genomics2023
37186939Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.J Immunol2023
36977669A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression.Nat Commun2023
37338709Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity.Clin Rev Allergy Immunol2023
36996700Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis.J Autoimmun2023
36853094Spontaneous development of an autoimmune hepatitis - primary biliary cholangitis overlap syndrome in dnTGFβRII Aire<sup>-/-</sup> mice.J Pathol2023
36684809PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales.J Transl Autoimmun2023
36642058Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.J Autoimmun2023
36464226Posterior reversible encephalopathy syndrome and autoimmunity.Autoimmun Rev2023
36737299Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study.J Autoimmun2023
36799463P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.Hepatology2023
36309918Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.Hepatol Int2023
34035120Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.Gut2022
35753523NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitis.J Hepatol2022
35514982Single-Cell Characterization of Hepatic CD8<sup>+</sup> T Cells in a Murine Model of Primary Biliary Cholangitis.Front Immunol2022
36604023Primary biliary cholangitis: personalized medicine for optimal therapeutic opportunities.Sci Bull (Beijing)2022
36251242New Mechanistic Advances in FcεRI-Mast Cell-Mediated Allergic Signaling.Clin Rev Allergy Immunol2022
36213422Steroid-induced osteonecrosis.J Transl Autoimmun2022
36209690GWAS and autoimmunity: What have we learned and what next.J Autoimmun2022
36042351Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression.Cell Mol Immunol2022
36041291Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.J Autoimmun2022
35928756The gut microbiome contributes to splenomegaly and tissue inflammation in a murine model of primary biliary cholangitis.Ann Transl Med2022
36059513Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis.Front Immunol2022
36029718Dual B-cell targeting therapy ameliorates autoimmune cholangitis.J Autoimmun2022
36119102New insights on the role of human leukocyte antigen complex in primary biliary cholangitis.Front Immunol2022
33512642Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.Clin Rev Allergy Immunol2022
33666868Correction to: Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Singleâ¿¿Center Experience and Literature Review.Clin Rev Allergy Immunol2022
35184318Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1.Hepatology2022
35040733An update on novel pharmacological agents for primary sclerosing cholangitis.Expert Opin Ther Targets2022
34971632Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.J Immunol Methods2022
35322189FoxO1 suppresses IL-10 producing B cell differentiation via negatively regulating Blimp-1 expression and contributes to allergic asthma progression.Mucosal Immunol2022
34608663E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants.Hepatology2022
34461299Morphological, Functional, and Tissue Characterization of Silent Myocardial Involvement in Patients With Primary Biliary Cholangitis.Clin Gastroenterol Hepatol2022
33276307Mushrooms and immunity.J Autoimmun2021
33710617Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis.Eur J Immunol2021
33727152Antibody glycosylation in autoimmune diseases.Autoimmun Rev2021
33554350The Clinical Significance of Hepatic CD69<sup>+</sup> CD103<sup>+</sup> CD8<sup>+</sup> Resident-Memory T Cells in Autoimmune Hepatitis.Hepatology2021
34994163Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.Front Biosci (Landmark Ed)2021
34437819Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.Gut Microbes2021
34495298Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.J Exp Med2021
34425712Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectives.Expert Rev Clin Immunol2021
  • 1 - 50 of 1,310

Recommended Authors

Andrew Wang
Yale University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Piper M Treuting
University of Washington
Career Start Year 1998
Number of shared co-authors 0
Hui-Chen Hsu
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 1
Frances E Lund
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Chander Raman
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Hector Melin-Aldana
Ann & Robert H. Lurie Children's Hospital of Chicago
Career Start Year 1990
Number of shared co-authors 0
Qi Wu
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Michael J Clare-Salzler
University of Florida College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Antony Rosen
Johns Hopkins University
Career Start Year 1988
Number of shared co-authors 0
Laura Santambrogio
Weill Cornell School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Chaim Putterman
Albert Einstein College of Medicine
Career Start Year 1986
Number of shared co-authors 2
Minoru Satoh
University of Occupational and Environmental Health
Career Start Year 1986
Number of shared co-authors 1
Hiroshi Ohno
RIKEN Center for Integrative Medical Sciences
Career Start Year 1986
Number of shared co-authors 0
Jody L Baron
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 0
Timothy W Behrens
Genentech Inc.
Career Start Year 1983
Number of shared co-authors 8
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
David R Karp
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 3
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
John D Mountz
University of Alabama at Birmingham and Birmingham VA Medical Center.
Career Start Year 1978
Number of shared co-authors 2
Robert P Searles
Oregon Health & Science University
Career Start Year 1977
Number of shared co-authors 0
Ann Marshak-Rothstein
University of Massachusetts School of Medicine
Career Start Year 1976
Number of shared co-authors 1
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 3
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 1
Hilary S Warren
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 1
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 0
Anthony P Monaco
Monash University
Career Start Year 1958
Number of shared co-authors 3
John B Harley
US Department of Veterans Affairs Medical Center
Career Start Year 1956
Number of shared co-authors 12

Collaborators

Ross L Coppel
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Co-authored papers 171
Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Co-authored papers 93
Ana Lleo
Humanitas University
Co-authored papers 45
Ruqi Tang
Co-authored papers 40
Michael F Seldin
University of California davis
Co-authored papers 21
Gideon M Hirschfield
University of Toronto
Co-authored papers 17
Leonard D Shultz
The Jackson Laboratory Cancer Center
Co-authored papers 12
Howard A Young
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Christopher I Amos
Baylor College of Medicine
Co-authored papers 5
Ping Xu
Co-authored papers 5
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 5
Daniele Cusi
Institute of Biomedical Technologies, National Research Council of Italy
Co-authored papers 4
Emanual Maverakis
Co-authored papers 4
Gang Xie
Chaohu Hospital Affiliated to Anhui Medical University
Co-authored papers 3
Peter K Gregersen
Co-authored papers 3
Sarah Alice Long
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 3
Sandeep Dhaliwal
University of California at Davis School of Medicine
Co-authored papers 3
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 2
Julio C Valencia
Co-authored papers 2
Konstantinos N Lazaridis
Mayo Clinic
Co-authored papers 2
Yafang Li
University of Michigan ann arbor
Co-authored papers 2
Rosanna Asselta
Co-authored papers 2
Jeffrey R Gruen
Yale Medical School
Co-authored papers 2
Samuel W French
Co-authored papers 2
Xiangdong Liu
Co-authored papers 2
Shanna H Swan
Co-authored papers 2
L J McNeilage
Co-authored papers 2
Ming Shi
Co-authored papers 2
Brian D Juran
Mayo Clinic
Co-authored papers 2
Amiran Dzutsev
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Release 1.2